Metabolic illnesses change ACE2 articulation and increment COVID-19 seriousness Kumar Jeetendra | June 9, 2020 As the COVID-19 pandemic keeps on causing sickness and take lives over the world, plainly the infection influences distinctive populace fragments divergently. Another examination distributed on the preprint server medRxiv* in June 2020 reports that one instrument for this variable seriousness is the differential articulation of the ACE2 receptor in different metabolic conditions, along these …
Scientist grows new medication to treat type 2 diabetes without undesired reactions Kumar Jeetendra | June 24, 2020 Syracuse University science educator Dr. Robert P. Doyle has built up another medication lead to treat type 2 diabetes in a great many patients who are looking to all the more likely control their glucose without the basic symptoms of queasiness, spewing, and in select cases, undesired weight reduction. Doyle’s examination article, “Corrination of a …
Examination distinguishes explicit brain cells that trigger sugar utilization and longings Kumar Jeetendra | July 18, 2020 New research has identified the particular brain cells that control just how much sugar you eat and how much you crave sweet tasting meals. Most people like a candy treat every now and then. However an unchecked”sweet tooth” can lead to overconsumption of sugary foods and chronic health problems such as obesity and type two …
Pancreatic β cell-inferred exosomal miR-29s control glucose homeostasis Kumar Jeetendra | January 24, 2021 In a new study published in Journal of Extracellular Vesicles, Chen-Yu Zhang’s team at Nanjing University, School of Life Sciences, and Antonio Vidal-Puig’s group at University of Cambridge report that pancreatic β cells secrete miR-29 family members (miR-29s) via exosomes in reaction to high levels of free fatty acids (FFAs). Formerly, Chen-Yu Zhang’s team identified …
Hereditary components of human gut microbiota are key to wellbeing Kumar Jeetendra | February 6, 2021 Neanderthals’ gut microbiota already contained some beneficial micro-organisms that are also found within our own intestine. An international research group headed by the University of Bologna achieved this result by extracting and analyzing ancient DNA from 50,000-year-old fecal sediments sampled at the archaeological site of El Salt, near Alicante (Spain). Published in Communication Biology, their …
Novel finding could prompt better medicines for Type 1 and Type 2 diabetes Kumar Jeetendra | February 13, 2021 Monash University researchers have discovered the barrier to β-cell (beta mobile ) regeneration which could pave the way for improved treatments for diabetes and diseases that involve organ and tissue damage. The human body does not repair itself very well, with our liver the only organ that can regenerate economically. We have limited capacity to …
Genomic surveillance can help recognize how SARS-CoV-2 spreads in care homes Kumar Jeetendra | March 4, 2021 Care homes are at high risk of experiencing outbreaks of COVID-19, the disease brought on by SARS-CoV-2. Older people and people affected by heart disease, respiratory disease and type 2 diabetes – all of which increase with age – are at greatest risk of severe disease and even death, which makes the care home population …
FDA supports new medication for therapy of adults with chronic kidney infection Kumar Jeetendra | May 1, 2021 Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood …
Growing genomic research into different ancestries yields more and better outcomes Kumar Jeetendra | June 1, 2021 Currently published in Nature Genetics, their findings demonstrate that expanding research into different ancestries yields more and better results, in addition to ultimately benefitting global patient care. Up to now nearly 87 percent of genomic research of the type was conducted in Europeans. The global study team examined data across a wide assortment of cohorts, …
